Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group.
Mosele MF, Westphalen CB, Stenzinger A, Barlesi F, Bayle A, Bièche I, Bonastre J, Castro E, Dienstmann R, Krämer A, Czarnecka AM, Meric-Bernstam F, Michiels S, Miller R, Normanno N, Reis-Filho J, Remon J, Robson M, Rouleau E, Scarpa A, Serrano C, Mateo J, André F.
Ann Oncol. 2024 Jul;35(7):588-606. doi: 10.1016/j.annonc.2024.04.005. Epub 2024 May 27.
Tissue-specific and interpretable sub-segmentation of whole tumour burden on CT images by unsupervised fuzzy clustering.
Rundo L, Beer L, Ursprung S, Martin-Gonzalez P, Markowetz F, Brenton JD, Crispin-Ortuzar M, Sala E, Woitek R.
Comput Biol Med. 2020 May;120:103751. doi: 10.1016/j.compbiomed.2020.103751. Epub 2020 Apr 10.
Evaluation of minimal disseminated disease in cryopreserved ovarian tissue from bone and soft tissue sarcoma patients.
Dolmans MM, Iwahara Y, Donnez J, Soares M, Vaerman JL, Amorim CA, Poirel H.
Hum Reprod. 2016 Oct;31(10):2292-302. doi: 10.1093/humrep/dew193. Epub 2016 Sep 2.
Trabectedin: Supportive care strategies and safety profile.
Jordan K, Jahn F, Jordan B, Kegel T, Müller-Tidow C, Rüssel J.
Crit Rev Oncol Hematol. 2015 Jun;94(3):279-90. doi: 10.1016/j.critrevonc.2015.02.012. Epub 2015 Mar 6.
Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction.
St John MA, Tao W, Fei X, Fukumoto R, Carcangiu ML, Brownstein DG, Parlow AF, McGrath J, Xu T.
Nat Genet. 1999 Feb;21(2):182-6. doi: 10.1038/5965.
Ovarian tissue cryopreservation for cancer patients: who is appropriate?
Seymour JF.
Reprod Fertil Dev. 2001;13(1):81-9. doi: 10.1071/rd00075.
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group.
Grignani G, D'Ambrosio L, Pignochino Y, Palmerini E, Zucchetti M, Boccone P, Aliberti S, Stacchiotti S, Bertulli R, Piana R, Miano S, Tolomeo F, Chiabotto G, Sangiolo D, Pisacane A, Dei Tos AP, Novara L, Bartolini A, Marchesi E, D'Incalci M, Bardelli A, Picci P, Ferrari S, Aglietta M.
Lancet Oncol. 2018 Oct;19(10):1360-1371. doi: 10.1016/S1470-2045(18)30438-8. Epub 2018 Sep 11.
A moderate thermal dose is sufficient for effective free and TSL based thermochemotherapy.
van Rhoon GC, Franckena M, Ten Hagen TLM.
Adv Drug Deliv Rev. 2020;163-164:145-156. doi: 10.1016/j.addr.2020.03.006. Epub 2020 Apr 2.
Imaging diagnosis of intravenous leiomyomatosis: an institutional experience.
Wang Q, Li Y, Gu X, Zhang N, Xie J, Niu B, Xing Y, He Y.
Clin Radiol. 2023 Sep;78(9):655-660. doi: 10.1016/j.crad.2023.03.017. Epub 2023 Apr 17.
Second cancers in 475 000 women with early invasive breast cancer diagnosed in England during 1993-2016: population based observational cohort study.
McGale P, Dodwell D, Challenger A, Cutter D, Williams A, Broggio J, Darby S, Mannu G, Taylor C.
BMJ. 2025 Aug 27;390:e083975. doi: 10.1136/bmj-2024-083975.
